rs78534766

This is a protein-altering variant in the ADCY7 gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

eosinophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.12
p 9.0e-17
N 408,112
Large GWAS
European
Allele A
OR 0.09
p 2.0e-14
N 394,642
Large GWAS
European

autoimmune thyroid disease

Allele A
OR 1.46
p 1.0e-14
N 754,406
Large GWAS
European

clinical treatment

Jiang L et al. A generalized linear mixed model association tool for biobank-scale data. Nature Genetics 53(11):1616-1621 (2021)
Allele A
OR 0.45
p 5.0e-10
N 456,276
Large GWAS
European

eosinophil count

Allele A
OR
p 1.0e-11
N 583,850
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.10
p 1.0e-11
N 408,112
Large GWAS
European

hypothyroidism

Allele A
OR 0.29
p 9.0e-42
N 1,786,062
Large GWAS
European
Allele A
OR 0.31
p 3.0e-26
N 1,178,661
Large GWAS
European
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele A
OR 0.38
p 1.0e-9
N 583,911
Large GWAS
multi-ancestry
Allele A
OR 0.38
p 8.0e-15
N 494,577
Large GWAS
European

About ADCY7

This gene encodes a membrane-bound adenylate cyclase that catalyses the formation of cyclic AMP from ATP and is inhibitable by calcium. The product of this gene is a member of the adenylyl cyclase class-4/guanylyl cyclase enzyme family that is characterized by the presence of twelve membrane-spanning domains in its sequences. Several transcript variants have been observed for this gene, but the full-length natures of only two have been determined so far. [provided by RefSeq, Oct 2013]

View all ADCY7 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…